| Indicators | Browse All

Drugs Made In America Acquisition II Corp. (DMIIU)

Financial Services | Shell Companies | New York, United States | NasdaqGM
10.16 USD

Short-term:⯪☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 6:20 a.m. EDT

This shell company presents a severe fundamental trap with no path to investment viability. The balance sheet is structurally broken, showing negative book value and a current ratio below 0.6, while operating cash flow is deeply negative, indicating active capital destruction rather than preservation. Despite the recent IPO pricing activity, the lack of any historical price trajectory or earnings data confirms there is no multi-year business quality to assess; the market has effectively priced this as a speculative vehicle with no intrinsic value floor. With zero dividend history and a deteriorating financial structure, the security offers no income and no growth catalyst, making it a clear avoidance for any rational capital allocation strategy.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.006304
MSTL0.006860
AutoETS0.006872
AutoARIMA0.006879

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 84%
H-stat 2.36
Ljung-Box p 0.000
Jarque-Bera p 0.669
Excess Kurtosis 0.23
Attribute Value
Sector Financial Services

Info Dump

Attribute Value
52 Week Change 0.017017007
Address1 420 Lexington Avenue
Address2 Suite 1402
All Time High 10.8
All Time Low 9.935
Ask 10.12
Ask Size 49
Average Daily Volume10 Day 0
Average Daily Volume3 Month 1,268
Average Volume 1,268
Average Volume10Days 0
Bid 9.96
Bid Size 1
Book Value -0.28
City New York
Country United States
Crypto Tradeable 0
Currency USD
Current Price 10.16
Current Ratio 0.528
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 10.16
Day Low 10.16
Display Name Drugs Made In America Acquisition II
Ebitda Margins 0.0
Enterprise Value 647,294,272
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 10.1292
Fifty Day Average Change 0.030799866
Fifty Day Average Change Percent 0.0030407007
Fifty Two Week Change Percent 1.7017007
Fifty Two Week High 10.8
Fifty Two Week High Change -0.64000034
Fifty Two Week High Change Percent -0.05925929
Fifty Two Week Low 9.935
Fifty Two Week Low Change 0.22499943
Fifty Two Week Low Change Percent 0.022647148
Fifty Two Week Range 9.935 - 10.8
Financial Currency USD
First Trade Date Milliseconds 1,758,807,000,000
Float Shares 50,258,026
Full Exchange Name NasdaqGM
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.010670001
Held Percent Institutions 0.0684
Industry Shell Companies
Industry Disp Shell Companies
Industry Key shell-companies
Ipo Expected Date 2,025-09-25
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.
Long Name Drugs Made In America Acquisition II Corp.
Market us_market
Market State REGULAR
Max Age 86,400
Message Board Id finmb_1938104325
Most Recent Quarter 1,774,915,200
Net Income To Common 8,584,197
Next Fiscal Year End 1,798,675,200
Open 10.16
Operating Cashflow -1,110,690
Operating Margins 0.0
Phone 917 982 4565
Previous Close 10.16
Price Hint 2
Price To Book -36.285713
Profit Margins 0.0
Quick Ratio 0.522
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0
Regular Market Change Percent 0.0
Regular Market Day High 10.16
Regular Market Day Low 10.16
Regular Market Day Range 10.16 - 10.16
Regular Market Open 10.16
Regular Market Previous Close 10.16
Regular Market Price 10.16
Regular Market Time 1,783,454,400
Regular Market Volume 3
Sand P52 Week Change 0.20365608
Sector Financial Services
Sector Disp Financial Services
Sector Key financial-services
Shares Short 136
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 122
Short Name Drugs Made In America Acquisiti
Short Ratio 0.25
Source Interval 15
State NY
Symbol DMIIU
Total Cash 347,720
Total Cash Per Share 0.005
Total Debt 450,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 10.056387
Two Hundred Day Average Change 0.1036129
Two Hundred Day Average Change Percent 0.010303194
Type Disp Equity
Volume 3
Zip 10,170